US$ 27.81
glp-1 and blood clots Deep Vein Thrombosis (DVT) & can semaglutide cause blood clots
Description
Novo Nordisks stock experienced significant declines following the release of the REDEFINE 1 trial results, partly due to investor expectations not being met

GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound have gained widespread attention for their effectiveness in aiding weight loss and managing Type 2 diabetes
These studies were designed by Novo Nordisk, with the data analysed by the Novo Nordisk authors, and has been interpreted and the conclusions drawn by the Novo Nordisk authors
A single dose might transiently affect anxiety circuits

JendleJNauckMAMatthewsDRFridAHermansenKDringMet al
